27 results
10-K
2023 FY
IMCR
Immunocore Holdings plc
28 Feb 24
Annual report
7:33am
by country / region based on the location of the customer below.
United States
Europe
International
Total revenue from the sale of therapies … have been rare. If the failure rate increased substantially, we could experience increased costs, lost revenue, damage to customer relations, time
6-K
EX-99.2
IMCR
Immunocore Holdings plc
7 Nov 23
Current report (foreign)
7:09am
that control transfers to a customer, which is typically on delivery to our distributors and healthcare providers. We also operate under consignment … to which we expect to be entitled, net of estimated deductions for rebates, chargebacks, other customer fees and product returns. These estimates
6-K
EX-99.1
IMCR
Immunocore Holdings plc
7 Nov 23
Current report (foreign)
7:09am
of a compassionate use and early access program are presented by region based on the location of the customer below.
For the Three Months Ended
September 30 … is presented after estimated deductions for rebates, chargebacks, other customer fees and returns.
Pre-product revenue, net
There was no pre-product
6-K
EX-99.1
IMCR
Immunocore Holdings plc
10 Aug 23
Current report (foreign)
8:28am
from the sale of tebentafusp as part of a compassionate use and early access program are presented by region based on the location of the customer below … . Revenue is presented after estimated deductions for rebates, chargebacks, other customer fees and returns.
Pre-product revenue, net
There was no pre
6-K
EX-99.2
IMCR
Immunocore Holdings plc
10 Aug 23
Current report (foreign)
8:28am
following marketing approval. We recognize product revenue at the point in time that control transfers to a customer, which is typically on delivery … deductions for rebates, chargebacks, other customer fees and product returns. These estimates consider contractual and statutory requirements, the expected
6-K
EX-99.1
mdrcxy
10 May 23
Current report (foreign)
7:27am
6-K
EX-99.2
sodozzee12wre
10 May 23
Current report (foreign)
7:27am
6-K/A
EX-99.1
lmbgy 9cm0m5a
18 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
4:17pm
6-K
EX-99.4
9m1v7u3wr4izd6f26 fz
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am
6-K
EX-99.2
hyw3082p7
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am
6-K
EX-99.1
lbzwqo5d9cbxtxd2
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am
6-K
EX-99.1
yh9b4fulb2qx7ctshkr
10 Aug 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
8:00am
6-K
EX-99.2
92kcxncj
10 Aug 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
8:00am
6-K
EX-99.1
xho7i45t
20 Jul 22
Securities Purchase Agreement
4:06pm
6-K
EX-99.1
i9snh1f
11 May 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:08am
6-K
EX-99.2
mdkatut8ax8ktqy0
11 May 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:08am
6-K
EX-99.1
fltv5
10 Nov 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:01am
20-F
67fc6z jiw4vks7
25 Mar 21
Annual report (foreign)
7:01am
424B4
bf83key
8 Feb 21
Prospectus supplement with pricing info
8:36am